跳至主要内容
临床试验/ISRCTN45336965
ISRCTN45336965已完成未知

An open-label, randomized, two-period crossover study to explore the pharmacokinetics of diltiazem solution released from the IntelliCap as compared to a marketed diltiazem 60 mg extended release capsule in healthy volunteers

Medimetrics Personalized Drug Delivery B.V. (Netherlands)0 个研究点目标入组 14 人开始时间: 2014年2月25日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
14

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Male

入选标准

  • 1. Provision of informed consent
  • 2. Healthy male subjects age 18 to 45 years of age inclusive
  • 3. Vital signs: body temperaturebetween 35.0 and 37.5 °C, systolic blood pressure 90-140 mmHg, diastolic blood pressure 60-90 mmHg, pulse rate 50-90 bpm
  • 4. Body weight > 50 kg, BMI 18 to 29 kg/m2

排除标准

  • 1. Smoking
  • 2. Use of prescription drugs, herbal supplements, over the counter medication
  • 3. Significant ECG (electrocardiogram) abnormalities
  • 4. Surgical or medical condition which might significantly alter the absorption, distribution, metabolism or excretion of drugs
  • 5. Impaired renal function
  • 6. Pacemakers or other implanted electro-medical devices
  • 7. Swallowing disorder
  • 8. Scheduled MRI assessment

研究者

发起方
Medimetrics Personalized Drug Delivery B.V. (Netherlands)

相似试验

已完成
1 期
An open-label, randomized, two-period crossover study to compare the pharmacokinetic and safety profile of single dose of TAK-070 (50 mg) under fed and fasting condition in healthy volunteerAlzheimer's diseases disease
JPRN-UMIN000018040nit for Early and Exploratory Clinical Development, The University of Tokyo Hospital8
已完成
不适用
A randomized, open-label, two-period, crossover study to determine the pharmacokinetics of reconstituted lyophilized Erelzi and Enbrel® (US-licensed) following a single subcutaneous injection in healthy male subjects.rheumatoid arthritis
NL-OMON45782Hexal AG56
进行中(未招募)
不适用
Comparison of the patient's experience with the methotrexate pre-filled syringe and with the methrotexate pre-filled pen and preference of the patient for subcutaneous methotrexate injection.MedDRA version: 15.1Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersRheumatoid Arthritis
EUCTR2012-000222-21-DEmedac Gesellschaft für klinische Spezialpräparate mbH
尚未招募
1 期
A study to find out the difference in absorption of same dose of drug prepared in 2 different forms, given one followed by the other to the same perso
CTRI/2009/091/000628ovartis Healthcare Private Limited16
进行中(未招募)
1 期
A study to compare how easily patients with breathing conditions (asthma, chronic obstructive pulmonary disease (COPD) and asthma COPD overlap syndrome) can use two different types of inhaler.
EUCTR2014-004564-38-DEMundipharma Research Limited368